Diabetes Market Research Reports & Industry Analysis
Glucose monitors have a major consumer-marketing component. While physicians may prescribe a monitor, the patient ultimately has the choice of which monitor s/he uses. Insulin provides very little consumer choice. The treatment regimen prescribed by the physician must be followed and there are very few market options. With Eli Lilly and Novo Nordisk being the two largest producers of insulin, it is highly likely that an insulin user will wind up using one of their products. As time goes by, the options of oral insulin and more intranasal insulin products may offer insulin dependent diabetics more variety in terms of products and delivery methods.
Hypoglycemic agents abound and vary in their composition and mode of action. For the most part, advanced cases of Type 2 diabetes require more than one of these drugs in order for the patient to maintain glycemic control. Because of the wide variety of these products, there is some room for pharmaceutical companies to influence diabetics toward using their products. In the end, the physician may have the last word, but that does not mean that the patient will stay with a physician who does not acquiesce to his/her wishes.
Diabetes Industry Research & Market Reports
-
Global Glucagon-like Peptide 1 (GLP-1) Market: Analysis By Product (Trulicity, Ozempic, Victoza, Rybelsus and Other GLP 1 Products), By Route of Administration (Injectable and Oral Medication), By Region Size and Trends with Impact of COVID-19 and Forecast up to 2027
... and Forecast up to 2027 GLP-1 receptor agonists are a type of non-insulin medication used to treat type 2 diabetes in conjunction with diet and exercise. These medications are used to help lower blood glucose ... Read More
-
Global Biosimilar Insulin Market Growth 2023-2029
... designed to be highly similar to the original, or reference, insulin product described in a patent. They are analogous to generic versions of small-molecule drugs and are developed by companies other than the reference product's ... Read More
-
Diabetic Foot Ulcer - Drug Pipeline Landscape, 2023
... is one of the health complications caused due to uncontrolled diabetes, people with diabetes may also suffer from lower extremity arterial disease, which is a condition that leads to reduced blood flow. These problems make ... Read More
-
Diabetic Gastroparesis - Drug Pipeline Landscape, 2023
... a digestive disorder with a high incidence among people with long-standing diabetes. Gastroparesis can cause due to the damage of vagus nerve. Certain medications, such as opioid pain relievers, some antidepressants, and high blood pressure ... Read More
-
2023 Global: Artificial Pancreas Device System (Adps) - Innovative Markets Forecast (2029) report
... data for the period 2018 through 2029. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2018 ... Read More
-
Global Diabetic Neurotherapy Foot Ulcers Market - 2023-2030
... at a CAGR of 8.4% during the forecast period (2023-2030). The most frequent foot wounds resulting in lower extremity amputation are diabetic ulcers. General practitioners are crucial in the early detection or prevention of diabetic ... Read More
-
Global Insulin Resistance Market - 2023-2030
... CAGR of 4.2% during the forecast period (2023-2030). Insulin resistance is an abnormally slow physiologic reaction to normal insulin concentrations. When cells in the muscles, fat, and liver do not respond to insulin well and ... Read More
-
Diabetic Retinopathy - Drug Pipeline Landscape, 2023
... blood causes blockage of the retina's small blood capillaries, impeding blood flow resulting in cloudy or blurred vision. There are two types of diabetic retinopathy non-proliferative diabetic retinopathy and proliferative diabetic retinopathy. A high sugar ... Read More
-
Diabetic Neuropathy - Drug Pipeline Landscape, 2023
... damage is called neuropathy. Diabetic neuropathy can affect different parts of the body, including the feet, legs, hands, and arms. It can also affect the digestive system, urinary system, blood vessels, and heart. Diabetic neuropathy ... Read More
-
In Vitro Diagnostics Market by Product and Service (Instruments, Kits, Software), Technology (Immunoassay, Hematology, Urinalysis), Application (Diabetes, Oncology, Cardiology, Infectious Disease), End User (Hospitals, Clinics) - Forecast to 2027
... to reach USD 144.7 billion by 2027 from USD 115.8 billion in 2022, at a CAGR of 4.6%. The growing adoption of point-of-care devices and rapid tests for early disease diagnosis, and the rising government ... Read More
-
Diabetic Nephropathy - Drug Pipeline Landscape, 2023
... of kidney to remove wastes and extra fluid from the body. The most common cause of Diabetic Nephropathy is Type 1 and Type 2 Diabetes which increase the blood pressure. Any damage caused to blood ... Read More
-
Global Compression Socks Market Growth 2023-2029
... ankle and up the leg and help relieve symptoms and slow the progress of varicose veins. They are designed to gently squeeze the legs, which promotes good blood flow in the veins. Patients with venous ... Read More
-
Diabetes Nutrition Market, by Form (Fixed Dental Prosthetic (Tablets, Capsules, Powders, Soft Gels, Liquids), by Product Type (Proteins & Amino Acids, Omega-3 Fatty Acids, Alpha-Lipoic Acid (ALA), Herbal Supplements, Soluble Fiber, Probiotics, Carbohydrates, Others (Antioxidants, etc.)), by Age Group (Paediatric, Adults), by Indication (Type 1 Diabetes, Type 2 Diabetes, Prediabetes, Gestational Diabetes), by Sales Channel (Hospitals, Retail Pharmacies, Online Pharmacies and Others (Wholesaler, Convenience Stores, etc.), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... etc.)), by Age Group (Paediatric, Adults), by Indication (Type 1 Diabetes, Type 2 Diabetes, Prediabetes, Gestational Diabetes), by Sales Channel (Hospitals, Retail Pharmacies, Online Pharmacies and Others (Wholesaler, Convenience Stores, etc.), and by Region (North ... Read More
-
Netherlands Diabetes Market, Size, Forecast 2023-2028, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis
... with no available cure. According to IDF Europe, there are more than 60 million diabetic people in the European Region; by 2045, this number will rise by 13%. In the Netherlands, the prevalence of diabetes ... Read More
-
Artificial Pancreas Device System Market Report: Trends, Forecast and Competitive Analysis
... medical centers. The global artificial pancreas device system market is expected to grow with a CAGR of 13% to 15% from 2023 to 2028. The major drivers for this market are increasing prevalence of diabetes, ... Read More
-
Global Food Intolerance Products Market Research Report 2022-2032
... According to a recently published report by Fatpos Global on “Food Intolerance Products Market” delivers a detailed overview of the market in terms of market segmentation by material type, by thickness, by application, by transparency, ... Read More
-
United Kingdom Diabetes Market, Size, Forecast 2023-2028, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis
... the worst diabetes condition in Europe, with the most overweight and obese adults, according to the WHO. As a result, United Kingdom, have more people than ever with diabetes. Diabetes is a chronic disease that ... Read More
-
United States Diabetes Market, Size, Forecast 2023-2028, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis
... United States, Diabetes is the 7th leading cause of death. Diabetes is a persistent disease that happens either when the pancreas has not produced enough insulin or when the body cannot effectively and efficiently uses ... Read More
-
Type 2 Diabetes Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2019-2029
... a defect in insulin secretion and sensitivity, whereby the β-cells in the pancreas fail to secrete sufficient amounts of insulin and cells fail to uptake adequate amounts of insulin due to loss of sensitivity, commonly ... Read More
-
Hyperglycemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hyperglycemia - Drugs In Development, 2022, provides an overview of the Hyperglycemia (Metabolic Disorders) pipeline landscape. Hyperglycemia is a condition that occurs when blood glucose levels get ... Read More
-
Tonometry Device Market, by DeviceType (Applanation Tonometers, Pascal Dynamic Contour Tonometers, Rebound Tonometers, Indentation Tonometers), by Application (Heart failure, Hypertension, Arteriosclerosis, Others (COPD, and Diabetes etc.)), by End User (Hospitals, Specialty Clinics and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 Tonometry means "to measure pressure" while applanation means "to flatten out." Radial artery ... Read More
-
Type 2 Diabetes Treatment: Global Market Outlook
... 2 diabetes treatment market and analyses market trends. Using 2021 as the base year, it provides estimated market data for the forecast period of 2022 to 2027. Revenue forecasts for this period are segmented based ... Read More
-
MENAT Syringe Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Syringe Type (Luer Lock Syringes, Glass Syringes, Luer Slip Syringes, and Others), Application (Aesthetics, Human Health, Lab / Industrial, and Others), Usability (Sterilizable/Reusable Syringes and Disposable Syringes), and End User (Hospitals & Clinics, Blood Collection Centers, Diabetic Care Centers, and Others)
... (Sterilizable/Reusable Syringes and Disposable Syringes), and End User (Hospitals & Clinics, Blood Collection Centers, Diabetic Care Centers, and Others) The MENAT syringe market is expected to grow from US$ 882.66 million in 2021 to US$ ... Read More
-
Artificial Pancreas Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update
... and Countries, Regulatory Path and Key Companies, 2022 Update provides comprehensive information about the Artificial Pancreas pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials ... Read More
-
2023 Global Forecast for Blood Glucose Monitoring System Market (2024-2029 Outlook)-High Tech & Emerging Markets Report
... 50 countries. The global market is expected to increase from USD xx billion in 2024 to USD xx billion by 2029, at a CAGR of xx% from 2024 to 2029. Estimates on equipment or material ... Read More
Research Assistance
